Long-term clinical outcome after surgical or percutaneous coronary revascularization in hemodialysis patients

Circulation Journal

Volumn 78, Issue 4, 2014, Pages 986-992

  Kumada, Yoshitaka ^a,b   Ishii, Hideki ^c   Aoyama, Toru ^b   Kamoi, Daisuke ^b   Kawamura, Yoshihiro ^b   Sakakibara, Takashi ^b   Nogaki, Haruhiko ^a   Takahashi, Hiroshi ^d   Murohara, Toyoaki ^c  

^a Matsunami General Hospital   (Japan)

^b Nagoya Kyoritsu Hospital   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

Coronary revascularization; Follow up; Hemodialysis; Prognosis

Indexed keywords

AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS GRAFT; DEATH; DIABETES MELLITUS; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART DISEASE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEMODIALYSIS PATIENT; HUMAN; ISCHEMIC COLITIS; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MEDIASTINITIS; PERCUTANEOUS CORONARY INTERVENTION; REVASCULARIZATION; TREATMENT OUTCOME;

AGED; CORONARY ARTERY BYPASS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; RENAL DIALYSIS; RETROSPECTIVE STUDIES; SURGICAL PROCEDURES, ELECTIVE; SURVIVAL RATE; TIME FACTORS;

EID: 84897883510     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-13-1357     Document Type: Article

References (30)

1. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003; 108: 2154-2169.
2. Joki N, Hase H, Nakamura R, Yamaguchi T. Onset of coronary artery disease prior to initiation of haemodialysis in patients with end-stage renal disease. Nephrol Dial Transplant 1997; 12: 718-723.
3. Herzog CA. Kidney disease in cardiology. Nephrol Dial Transplant 2011; 26: 46-50.
4. Hemmelgarn BR, Southern D, Culleton BF, Mitchell LB, Knudtson ML, Ghali WA; Alberta provincial project for outcomes assessment in coronary heart disease (APPROACH) investigators. Survival after coronary revascularization among patients with kidney disease. Circulation 2004; 110: 1890-1895.
5. Yasuda K, Kasuga H, Aoyama T, Takahashi H, Toriyama T, Kawade Y, et al. Comparison of percutaneous coronary intervention with medication in the treatment of coronary artery disease in hemodialysis patients. J Am Soc Nephrol 2006; 17: 2322-2332.
6. Hillis GS, Croal BL, Buchan KG, El-Shafei H, Gibson G, Jeffrey RR, et al. Renal function and outcome from coronary artery bypass grafting: Impact on mortality after a 2.3-year follow-up. Circulation 2006; 113: 1056-1062.
7. Cooper WA, O'Brien SM, Thourani VH, Guyton RA, Bridges CR, Szczech LA, et al. Impact of renal dysfunction on outcomes of coronary artery bypass surgery: Results from the Society of Thoracic Surgeons National Adult Cardiac Database. Circulation 2006; 113: 1063-1070.
8. Yamauchi T, Miyata H, Sakaguchi T, Miyagawa S, Yoshikawa Y, Takeda K, et al. Coronary artery bypass grafting in hemodialysis-dependent patients: Analysis of Japan Adult Cardiovascular Surgery Database. Circ J 2012; 76: 1115-1120.
9. Natsuaki M, Furukawa Y, Morimoto T, Nakagawa Y, Akao M, Ono K, et al. Impact of diabetes on cardiovascular outcomes in hemodialy-sis patients undergoing coronary revascularization. Circ J 2011; 75: 1616-1625.
10. Otsuka Y, Ishiwata S, Inada T, Kanno H, Kyo E, Hayashi Y, et al. Comparison of haemodialysis patients and non-haemodialysis patients with respect to clinical characteristics and 3-year clinical outcomes after sirolimus-eluting stent implantation: Insights from the Japan multi-centre post-marketing surveillance registry. Eur Heart J 2011; 32: 829-837.
11. Herzog CA, Ma JZ, Collins AJ. Long-term outcome of dialysis patients in the United States with coronary revascularization procedures. Kidney Int 1999; 56: 324-332.
12. Herzog CA, Ma JZ, Collins AJ. Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes. Circulation 2002; 106: 2207-2211.
13. Szczech LA, Reddan DN, Owen WF, Califf R, Racz M, Jones RH, et al. Differential survival after coronary revascularization procedures among patients with renal insuffciency. Kidney Int 2001; 60: 292-299.
14. Chang TI, Shilane D, Kazi DS, Montez-Rath ME, Hlatky MA, Winkelmayer WC. Multivessel coronary artery bypass grafting versus percutaneous coronary intervention in ESRD. J Am Soc Nephrol 2012; 23: 2042-2049.
15. Nevis IF, Mathew A, Novick RJ, Parikh CR, Devereaux PJ, Natarajan MK, et al. Optimal method of coronary revascularization in patients receiving dialysis: Systematic review. Clin J Am Soc Nephrol 2009; 4: 369-378.
16. Aoki J, Ikari Y, Nakajima H, Sugimoto T, Hara K. Coronary revascu-larization improves long-term prognosis in diabetic and nondiabetic end-stage renal disease. Circ J 2002; 66: 595-599.
17. Aoki J, Ikari Y, Sugimoto T, Fukuda S, Hara K. Clinical outcome of percutaneous transluminal coronary rotational atherectomy in patients with end-stage renal disease. Circ J 2003; 67: 617-621.
18. Fujimoto Y, Ishiwata S, Dohi T, Masuda J, Fujimoto H, Mitani H, et al. Long-term prognosis after coronary revascularization in patients with end-stage renal disease on dialysis: Comparison of percutaneous coronary intervention and coronary artery bypass grafting. J Cardiol 2007; 50: 11-20.
19. Ashrith G, Lee VV, Elayda MA, Reul RM, Wilson JM. Short- and long-term outcomes of coronary artery bypass grafting or drug-eluting stent implantation for multivessel coronary artery disease in patients with chronic kidney disease. Am J Cardiol 2010; 106: 348-353.
20. Terazawa S, Tajima K, Takami Y, Tanaka K, Okada N, Usui A, et al. Early and late outcomes of coronary artery bypass surgery versus percutaneous coronary intervention with drug-eluting stents for dialysis patients. J Card Surg 2012; 27: 281-287.
21. Manabe S, Shimokawa T, Fukui T, Fumimoto KU, Ozawa N, Seki H, et al. Coronary artery bypass surgery versus percutaneous coronary artery intervention in patients on chronic hemodialysis: Does a drug-eluting stent have an impact on clinical outcome? J Card Surg 2009; 24: 234-239.
22. Sunagawa G, Komiya T, Tamura N, Sakaguchi G, Kobayashi T, Murashita T. Coronary artery bypass surgery is superior to percutaneous coronary intervention with drug-eluting stents for patients with chronic renal failure on hemodialysis. Ann Thorac Surg 2010; 89: 1896-1900.
23. Ishii H, Toriyama T, Aoyama T, Takahashi H, Yamada S, Kasuga H, et al. Effcacy of oral nicorandil in patients with end-stage renal disease: A retrospective chart review after coronary angioplasty in Japanese patients receiving hemodialysis. Clin Ther 2007; 29: 110-122.
24. Ishii H, Toriyama T, Aoyama T, Takahashi H, Tanaka M, Yoshikawa D, et al. Percutaneous coronary intervention with bare metal stent vs. drug-eluting stent in hemodialysis patients. Circ J 2012; 76: 1609-1615.
25. Williams ME. Coronary revascularization in diabetic chronic kidney disease/end-stage renal disease: A nephrologist's perspective. Clin J Am Soc Nephrol 2006; 1: 209-220.
26. Aoyama T, Ishii H, Toriyama T, Takahashi H, Kasuga H, Murakami R, et al. Sirolimus-eluting stents vs bare metal stents for coronary intervention in Japanese patients with renal failure on hemodialysis. Circ J 2008; 72: 56-60.
27. Kamoi D, Ishii H, Takahashi H, Aoyama T, Toriyama T, Tanaka M, et al. Sirolimus- vs. paclitaxel-eluting stent to coronary intervention in dialysis patients. Int J Cardiol 2013; 165: 533-536.
28. Sakakibara T, Ishii H, Toriyama T, Aoyama T, Takahashi H, Kamoi D, et al. Sirolimus-eluting stent vs. everolimus-eluting stent for coronary intervention in patients on chronic hemodialysis. Circ J 2012; 76: 351-355.
29. Miyagi N, Arai H. What is optimal revascularization for hemodialysis patients? Circ J 2012; 76: 1085-1086.
30. Goodkin DA, Bragg-Gresham JL, Koenig KG, Wolfe RA, Akiba T, Andreucci VE, et al. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: The Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol 2003; 14: 3270-3277.